In our cohort, SBS9 was observed in 4 cases: 2 low hypodiploid cases, 1 IGH::CEBPB and 1 IGK::BCL2 case with the highest mutation burden (42%), which we had expected, given the association of this lesion with mature B-cell neoplasms. The gene discussed is BCL2; the disease is B-cell neoplasm.